Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (100.0%)OC-01 (Varenicline) Nasal Spray and Dry Eye Signs and Symptoms in Daily Disposable Contact Lens Wearers
Phase 4
Completed
- Conditions
- Dry Eye
- Interventions
- Drug: OC-01 (varenicline 0.6mg/ml) Nasal SprayDrug: Placebo (vehicle) nasal spray
- First Posted Date
- 2021-12-17
- Last Posted Date
- 2022-11-03
- Lead Sponsor
- Center for Ophthalmic and Vision Research, LLC
- Target Recruit Count
- 75
- Registration Number
- NCT05161208
- Locations
- 🇺🇸
Center for Ophthalmic and Vision Recearch, New York, New York, United States
CEQUA for Sjogren's Syndrome Dry Eye
Phase 4
Completed
- Conditions
- Dry Eye SyndromesSjogren's SyndromeDry Eye
- Interventions
- First Posted Date
- 2021-04-08
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Center for Ophthalmic and Vision Research, LLC
- Target Recruit Count
- 50
- Registration Number
- NCT04835623
- Locations
- 🇺🇸
Center for Ophthalmic and Vision Recearch, Manhattan, New York, United States
News
No news found